Stay updated with breaking news from Wealthspan Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Sunday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of LPCN stock opened at $0.27 on Friday. Lipocine has a 12-month low of $0.23 and a 12-month high of […]
Raymond James Financial Services Advisors Inc. reduced its position in shares of Vanguard Mid-Cap Value ETF (NYSEARCA:VOE – Get Rating) by 12.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 374,724 shares of the company’s stock after selling 54,979 […]
LPL Financial LLC raised its stake in shares of Vanguard Mid-Cap Value ETF (NYSEARCA:VOE – Get Rating) by 7.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 913,591 shares of the company’s stock after buying an additional 61,700 shares during the quarter. LPL Financial LLC’s holdings in Vanguard Mid-Cap Value ETF were […]
Lansing Street Advisors trimmed its position in Vanguard Mid-Cap Value ETF (NYSEARCA:VOE – Get Rating) by 54.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,638 shares of the company’s stock after selling 9,092 shares during the quarter. Lansing Street Advisors’ holdings in […]
Lipocine Inc. (NASDAQ:LPCN – Get Rating) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,160,000 shares, a drop of 7.9% from the March 15th total of 1,260,000 shares. Currently, 1.4% of the company’s stock are short sold. Based on […]